European Journal of Hospital Pharmacy

Papers
(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Medicines Delivery Proximity Programme (PEMProxi) survey results71
Medical device resources for hospital pharmacists48
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations27
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent25
Medicine shortages in France: a 6-year retrospective study in a university medical centre18
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study17
Advanced therapy medicinal products16
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?15
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings14
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years13
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy13
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease12
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients12
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence11
Empowering European hospital pharmacists in the face of heart failure11
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings11
The threatened medicines information pharmacist!10
EJHP’s impact factor moves on up10
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey9
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report9
Hypoglycaemic coma induced by a falsified semaglutide product: a case report8
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology8
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze8
Optimisation of the quality of care for patients with severe asthma: ASfarMA project8
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis7
Design and validation of a predictive equation to estimate unbound valproic acid concentration7
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report7
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods7
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts7
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients6
The end of an era!6
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation6
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome6
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care6
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review5
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence5
Thoughts on the shortage of vinflunine: could we have done more?5
EMA guidance for industry to prevent and mitigate medicine shortages5
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C5
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness5
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi5
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report5
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations5
Beta-lactam allergy in patients: an antibiotic stewardship challenge5
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements4
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management4
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients4
Clinical trials4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time4
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab4
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database4
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction4
Show how you keep antibiotics working during this year’s EAAD4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 20234
RETRACTED: Specific features of rational pharmacotherapy in elderly patients4
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report4
Capecitabine: guaranteed access in adjuvant treatment of breast cancer3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20223
Update on the hospital pharmacist profile: from clinical practice to management3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge3
Penicillin allergy that persisted after 66 years: case report3
Medication adherence interventions: where are we and where do we go?3
Pharmacological resilience in the context of geopolitical tensions: a European perspective3
Organisational impact of in vivo gene therapies at two French injection centres3
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing3
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy3
Infectious diseases and antimicrobial resistance3
Role of EMA for crises strengthened3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report3
An antidote network in Spain, a tool to improve antidote availability in hospitals3
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review3
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-193
Medication-related problems in critical care survivors: a systematic review3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling3
Tocilizumab in COVID-19 management: addressing time of starting treatment3
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions3
Looking back and looking forward2
Comparison of the 22nd World Health Organization Model List of Essential Medicines with the explicit criteria for the treatment of chronicity in elderly patients2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin2
Antimicrobial resistance in Nigeria: challenges and charting the way forward2
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies2
Welcome to this online edition2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services2
Primary care electronic medication record discrepancies in patients starting treatment at a hospital-based ambulatory care pharmacy and impact on prevalence of potential drug–drug interactions2
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series2
Patient safety culture and medication safety in European intensive care units: a focus group study2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials2
Evaluation of resources for effective decision-making about drug manipulation2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?2
Analysing electronic prescribing data to detect potential undocumented adverse reactions to medications2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation2
Use of simulation for education in hospital pharmaceutical technologies: a systematic review2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Digital health2
Antimicrobial resistance: a major priority for global focus2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy2
Liquid antimicrobials: a national analysis of critical shortages2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques2
Results of EAHP’s 2023 shortages survey2
Access to medicines2
Introduction to an online only issue2
When gravimetry is debated by sponsors of clinical studies2
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document2
Public information on shortages in the EU/EEA: improvements made between 2018 and 20202
European health data space proposal launched2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?2
To maximise impact, hospital pharmacists need to increase visibility2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study2
Safeguarding antimicrobial medicines reserved for treating humans2
Drug intoxication: a silent obstacle to organ donation2
Importance of medication reconciliation, even in the absence of positive data2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia2
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD2
Implementation of pharmacists’ monitoring for intravenous drug compatibility2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp2
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?2
Study of therapeutic patient education practices in French renal transplantation centres2
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis2
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava2
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals2
Defining a new term: defensive hospital pharmacy practices2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future2
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs2
Unit dose drug dispensing systems in hospitals: a systematic review of medication error reduction and cost-effectiveness2
Comparison of adverse drug reactions of statins in China from 1989 to 20192
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 12
0.029775857925415